Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Awol Mekonnen Ali, Haileyesus Adam, Daniel Hailu, Rawleigh Howe, Teferra Abula & Marieke JH Coenen. (2023) Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia. The Application of Clinical Genetics 16, pages 131-137.
Read now
Read now
Melissa Sandley & Jonathan Angus. (2023) Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management. Leukemia & Lymphoma 64:4, pages 776-787.
Read now
Read now
Cynthia Bender, Luke Maese, Maria Carter-Febres & Anupam Verma. (2021) Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review. Blood and Lymphatic Cancer: Targets and Therapy 11, pages 25-40.
Read now
Read now
Saveria Capria, Matteo Molica, Sara Mohamed, Simona Bianchi, Maria Luisa Moleti, Silvia Maria Trisolini, Sabina Chiaretti & Anna Maria Testi. (2020) A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia. Expert Review of Hematology 13:7, pages 755-769.
Read now
Read now
Wanda Salzer, Bruce Bostrom, Yoav Messinger, Anthony J. Perissinotti & Bernard Marini. (2018) Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia. Leukemia & Lymphoma 59:8, pages 1797-1806.
Read now
Read now
Michael J. Burke, Meenakshi Devidas, Kelly Maloney, Anne Angiolillo, Reuven Schore, Kimberly Dunsmore, Eric Larsen, Len A. Mattano$suffix/text()$suffix/text(), Wanda Salzer, Stuart S. Winter, William Carroll, Naomi J. Winick, Mignon L. Loh, Elizabeth Raetz, Stephen P. Hunger & Archie Bleyer. (2018) Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials. Leukemia & Lymphoma 59:7, pages 1624-1633.
Read now
Read now
Michael J. Burke & Susan R. Rheingold. (2017) Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. Leukemia & Lymphoma 58:3, pages 540-551.
Read now
Read now
Nobuko Hijiya & Inge M. van der Sluis. (2016) Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leukemia & Lymphoma 57:4, pages 748-757.
Read now
Read now
Lisa Figueiredo, Peter D. Cole & Richard A. Drachtman. (2016) Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase. Expert Review of Hematology 9:3, pages 227-234.
Read now
Read now
Vladan Rajić, Maruša Debeljak, Katja Goričar & Janez Jazbec. (2015) Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia. Leukemia & Lymphoma 56:11, pages 3103-3108.
Read now
Read now
Barbara Asselin & Carmelo Rizzari. (2015) Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leukemia & Lymphoma 56:8, pages 2273-2280.
Read now
Read now
Wanda Salzer, Nita Seibel & Malcolm Smith. (2012)
Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Opinion on Biological Therapy 12:10, pages 1407-1414.
Read now
Read now
Wendy Stock, Dan Douer, Daniel J. DeAngelo, Martha Arellano, Anjali Advani, Lloyd Damon, Tibor Kovacsovics, Mark Litzow, Michael Rytting, Gautam Borthakur & Archie Bleyer. (2011) Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leukemia & Lymphoma 52:12, pages 2237-2253.
Read now
Read now
Henk van den Berg. (2011) Asparaginase revisited. Leukemia & Lymphoma 52:2, pages 168-178.
Read now
Read now
Marion Strullu, Nadège Corradini, Marie Audrain, Jean-Luc Orsonneau, Daniel Bouige, Patrick Thomare, Claudine Vermot-Desroches, Adeline Mansuy, Arnaud Legrand, Jean-Christophe Rozé, Mohamad Mohty & Françoise Méchinaud. (2010) Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia. Leukemia & Lymphoma 51:8, pages 1464-1472.
Read now
Read now
G. Mann, M. Steiner & A. Attarbaschi. (2007) Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Leukemia & Lymphoma 48:5, pages 849-850.
Read now
Read now
Articles from other publishers (46)
Gabriela Burgueño-Rodríguez, Yessika Méndez, Natalia Olano, Magdalena Schelotto, Luis Castillo, Ana María Soler & Julio da Luz. (2023) Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs. Frontiers in Pharmacology 14.
Crossref
Crossref
María Tosta Pérez, Lisandra Herrera Belén, Pablo Letelier, Yolanda Calle, Adalberto Pessoa & Jorge G. Farías. (2023) l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology 40:5.
Crossref
Crossref
Shawn H. R. Lee, Zhenhua Li, Evelyn H. Z. Lim, Winnie H. N. Chin, Nan Jiang, Kean Hui Chiew, Zhiwei Chen, Bernice L. Z. Oh, Ah Moy Tan, Hany Ariffin, Jun J. Yang & Allen E. J. Yeoh. (2023) Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic Leukemia. Cancers 15:6, pages 1829.
Crossref
Crossref
Hoda Pourhassan, Dan Douer, Vinod Pullarkat & Ibrahim Aldoss. (2022) Asparaginase: How to Better Manage Toxicities in Adults. Current Oncology Reports 25:1, pages 51-61.
Crossref
Crossref
Cristina Matteo, Antonella Colombini, Laura Rachele Bettini, Luca Porcu, Silvia Barzaghi, Tommaso Ceruti, Daniela Silvestri, Angela Amoroso, Fabiola Dell'Acqua, Giacomo Gotti, Claudia Nastasi, Massimo Zucchetti & Carmelo Rizzari. (2022)
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG‐
l
‐asparaginase product
. Pediatric Blood & Cancer 69:9.
Crossref
Crossref
Michael J Burke & Beata Zalewska-Szewczyk. (2022) Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences. Future Oncology 18:10, pages 1285-1299.
Crossref
Crossref
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M. Schalk, Veerle Mondelaers, Barbara De Moerloose, Arnon Lavie, Tim Lammens, Steven Goossens & Pieter Van Vlierberghe. (2022) Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers 14:4, pages 902.
Crossref
Crossref
Chenxi Liu, Binxiao Huang, Ruichi Wu, Jing Chen, Yanjing Tang, Wenting Hu, Jing Li, Xiaoxiao Chen, Jiaoyang Cai, Min Zhou, Changcheng Chen & Shuhong Shen. (2021) Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia. International Journal of Cancer 149:1, pages 158-168.
Crossref
Crossref
Lisandra Herrera Belén, Jorge F. Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Gisele Monteiro, Adalberto Pessoa & Jorge G. Farías. (2020) Immunogenicity assessment of fungal l-asparaginases: an in silico approach. SN Applied Sciences 2:2.
Crossref
Crossref
Yoko Tabe, Philip L. Lorenzi & Marina Konopleva. (2019) Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood 134:13, pages 1014-1023.
Crossref
Crossref
Clémence Merlen, Arnaud Bonnefoy, Cynthia Afeich, Yves Théorêt, Caroline Laverdière, Jean‐Marie Leclerc & Georges‐Etienne Rivard. (2019) Antithrombin and fibrinogen levels as predictors for plasma L‐asparaginase activity in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer 66:7, pages e27729.
Crossref
Crossref
Lisandra Herrera Belén, Jorge Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Brian Effer, Gisele Monteiro, Adalberto Pessoa & Jorge G. Farías Avendaño. (2019) A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora. Biologicals 59, pages 47-55.
Crossref
Crossref
Justyna Walenciak, Krystyna Wyka, Szymon Janczar, Wojciech Młynarski & Beata Zalewska-Szewczyk. (2019) Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment. Pharmacological Reports 71:2, pages 311-318.
Crossref
Crossref
Deepankar Sharma, Kushagri Singh, Kavita Singh & Abha Mishra. (2019) Insights into the Microbial L-Asparaginases: from Production to Practical Applications. Current Protein & Peptide Science 20:5, pages 452-464.
Crossref
Crossref
Larissa Pereira Brumano, Francisco Vitor Santos da Silva, Tales Alexandre Costa-Silva, Alexsandra Conceição Apolinário, João Henrique Picado Madalena Santos, Eduardo Krebs Kleingesinds, Gisele Monteiro, Carlota de Oliveira Rangel-Yagui, Brahim Benyahia & Adalberto Pessoa Junior. (2019) Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles. Frontiers in Bioengineering and Biotechnology 6.
Crossref
Crossref
Alexandra Louka, Irina Matlahov, Stefano Giuntini, Linda Cerofolini, Andrea Cavallo, Serena Pillozzi, Enrico Ravera, Marco Fragai, Annarosa Arcangeli, Ayyalusamy Ramamoorthy, Gil Goobes & Claudio Luchinat. (2018)
Engineering
l
-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors
. Physical Chemistry Chemical Physics 20:18, pages 12719-12726.
Crossref
Crossref
S.H. Lim, J.Y. Hong, S.T. Lim, H. Hong, J. Arnoud, W. Zhao, D.H. Yoon, T. Tang, J. Cho, S. Park, Y.H. Ko, S.J. Kim, C. Suh, T. Lin & W.S. Kim. (2017) Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Annals of Oncology 28:9, pages 2199-2205.
Crossref
Crossref
Bernard L. Marini, Anthony J. Perissinotti, Dale L. Bixby, Julia Brown & Patrick W. Burke. (2017) Catalyzing improvements in ALL therapy with asparaginase. Blood Reviews 31:5, pages 328-338.
Crossref
Crossref
Gabriela Galindo-Rodríguez, José C. Jaime-Pérez, Mario C. Salinas-Carmona, Sandra N. González-Díaz, Ángeles Castro-Corona, Raúl Cavazos-González, Humberto Treviño-Villarreal, Alberto C. Heredia-Salazar & David Gómez-Almaguer. (2017) Do immunoglobulin G and immunoglobulin E anti- l -asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study. Revista Brasileira de Hematologia e Hemoterapia 39:3, pages 202-209.
Crossref
Crossref
Maria Lopez-Santillan, Leire Iparraguirre, Idoia Martin-Guerrero, Angela Gutierrez-Camino & Africa Garcia-Orad. (2017)
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the
GRIA1
gene
. Drug Metabolism and Personalized Therapy 32:1, pages 1-9.
Crossref
Crossref
Małgorzata Czogała, Walentyna Balwierz, Krystyna Sztefko & Iwona Rogatko. (2017) Antithrombin III as the Indicator of l-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 39:2, pages 114-120.
Crossref
Crossref
Jennifer L. McNeer, Archie Bleyer, Valentino Conter & Wendy Stock. 2017. Cancer in Adolescents and Young Adults. Cancer in Adolescents and Young Adults
151
175
.
Barbara Asselin. (2016) Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia. Future Oncology 12:13, pages 1609-1621.
Crossref
Crossref
Lynda M. Vrooman, Ivan I. Kirov, ZoAnn E. Dreyer, Michael Kelly, Nobuko Hijiya, Patrick Brown, Richard A. Drachtman, Yoav H. Messinger, A. Kim Ritchey, Gregory A. Hale, Kelly Maloney, Yuan Lu, Paul V. Plourde & Lewis B. Silverman. (2015)
Activity and Toxicity of Intravenous
Erwinia
Asparaginase Following Allergy to
E
.
coli
‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
. Pediatric Blood & Cancer 63:2, pages 228-233.
Crossref
Crossref
Muaz Alrazzak, Lynda K. Beaupin, Peter Kinyoun & Matthew Barth. (2016) The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 38:1, pages e16-e20.
Crossref
Crossref
Shih-Hsiang Chen. (2015) Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance. Pediatrics & Neonatology 56:5, pages 287-293.
Crossref
Crossref
Nicolas BoisselLeonard S. Sender. (2015) Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. Journal of Adolescent and Young Adult Oncology 4:3, pages 118-128.
Crossref
Crossref
J. A. Kidd, P. Ross, A. S. Buntzman & P. R. Hess. (2015)
Development of an ELISA to detect circulating anti-asparaginase antibodies in dogs with lymphoid neoplasia treated with
Escherichia coli
l
-asparaginase
. Veterinary and Comparative Oncology 13:2, pages 77-88.
Crossref
Crossref
Michael J Burke. (2014) How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia. Future Oncology 10:16, pages 2615-2627.
Crossref
Crossref
Wanda L. Salzer, Barbara L. Asselin, Paul V. Plourde, Tim Corn & Stephen P. Hunger. (2014)
Development of asparaginase
Erwinia chrysanthemi
for the treatment of acute lymphoblastic leukemia
. Annals of the New York Academy of Sciences 1329:1, pages 81-92.
Crossref
Crossref
Carmelo Rizzari, Maria Caterina Putti, Antonella Colombini, Sara Casagranda, Giulia Maria Ferrari, Cristina Papayannidis, Ilaria Iacobucci, Maria Chiara Abbenante, Chiara Sartor & Giovanni Martinelli. (2014) Rationale for a Pediatric-Inspired Approach in the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia, with a Focus on Asparaginase Treatment. Hematology Reports 6:3, pages 5554.
Crossref
Crossref
Christos S. Karamitros, Alexey M. Yashchenok, Helmuth Möhwald, Andre G. Skirtach & Manfred Konrad. (2013) Preserving Catalytic Activity and Enhancing Biochemical Stability of the Therapeutic Enzyme Asparaginase by Biocompatible Multilayered Polyelectrolyte Microcapsules. Biomacromolecules 14:12, pages 4398-4406.
Crossref
Crossref
Antonio Ruggiero, Silvia Triarico, Giovanna Trombatore, Andrea Battista, Fabiola Dell’Acqua, Carmelo Rizzari & Riccardo Riccardi. (2013) Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer. European Journal of Clinical Pharmacology 69:10, pages 1739-1746.
Crossref
Crossref
Gillian M. Keating. (2013) Asparaginase Erwinia chrysanthemi (Erwinaze®): A Guide to Its Use in Acute Lymphoblastic Leukemia in the USA. BioDrugs 27:4, pages 413-418.
Crossref
Crossref
Sara E. Shinnick, Mary L. Browning & Susannah E. Koontz. (2013) Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults. Journal of Pediatric Oncology Nursing 30:2, pages 63-77.
Crossref
Crossref
Carmelo Rizzari, Valentino Conter, Jan Starý, Antonella Colombini, Anja Moericke & Martin Schrappe. (2013) Optimizing asparaginase therapy for acute lymphoblastic leukemia. Current Opinion in Oncology 25:Supplement 1, pages S1-S9.
Crossref
Crossref
Liang Wang, Zhi‐hui Wang, Xiao‐qin Chen, Ya‐jun Li, Ke‐feng Wang, Yun‐fei Xia & Zhong‐jun Xia. (2012) First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphoma. Cancer 119:2, pages 348-355.
Crossref
Crossref
C Liu, J D Kawedia, C Cheng, D Pei, C A Fernandez, X Cai, K R Crews, S C Kaste, J C Panetta, W P Bowman, S Jeha, J T Sandlund, W E Evans, C-H Pui & M V Relling. (2012) Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia 26:11, pages 2303-2309.
Crossref
Crossref
Raheel Altaf Raja, Kjeld Schmiegelow & Thomas Leth Frandsen. (2012) Asparaginase‐associated pancreatitis in children. British Journal of Haematology 159:1, pages 18-27.
Crossref
Crossref
Arnaud JaccardNathalie GachardBenoit MarinSylvie RogezMarie AudrainFelipe SuarezHervé TillyFranck MorschhauserCatherine ThieblemontLoic YsebaertAlain DevidasBarbara PetitLaurence de Leval, Philippe Gaulard, Jean FeuillardDominique BordessouleOlivier Hermine. (2011) Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 117:6, pages 1834-1839.
Crossref
Crossref
Rob Pieters, Stephen P. Hunger, Joachim Boos, Carmelo Rizzari, Lewis Silverman, Andre Baruchel, Nicola Goekbuget, Martin Schrappe & Ching‐Hon Pui. (2010) L‐asparaginase treatment in acute lymphoblastic leukemia. Cancer 117:2, pages 238-249.
Crossref
Crossref
Elizabeth A. Raetz & Wanda L. Salzer. (2010) Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 32:7, pages 554-563.
Crossref
Crossref
Shizuka Watanabe, Kumiko Miyake, Chitose Ogawa, Haruna Matsumoto, Kenichi Yoshida, Shinsuke Hirabayashi, Daisuke Hasegawa, Tadao Inoue, Junko Kizu, Reiko Machida, Akira Ohara, Ryota Hosoya & Atsushi Manabe. (2009) The ex vivo production of ammonia predicts l-asparaginase biological activity in children with acute lymphoblastic leukemia. International Journal of Hematology 90:3, pages 347-352.
Crossref
Crossref
Naina Patel, Shekhar Krishnan, Marc N. Offman, Marcin Krol, Catherine X. Moss, Carly Leighton, Frederik W. van Delft, Mark Holland, JiZhong Liu, Seema Alexander, Clare Dempsey, Hany Ariffin, Monika Essink, Tim O.B. Eden, Colin Watts, Paul A. Bates & Vaskar Saha. (2009) A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase. Journal of Clinical Investigation.
Crossref
Crossref
Ozge Uysal Soyer, Selin Aytac, Ayfer Tuncer, Mualla Cetin, Sevgi Yetgin & Bulent Enis Sekerel. (2009) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. Journal of Allergy and Clinical Immunology 123:4, pages 895-899.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref
Crossref